SpaceX Scrubs Starship Test Flight Reschedules for Friday Debut AIs Role in Shaping Quarterly Earnings and Market Outlooks India Government Plans Major Overhaul of Tax Administration to Facilitate Smooth GST Rollout NOXCAT Emphasizes Staking as LongTerm Commitment Not ShortTerm Speculation Ubers Takeover Bid for Delivery Hero Reportedly Rejected Lithuania Data Breach Exposes 600000 National Records Spy Addresses at Risk RMCO Q4 2025 Earnings Significant EPS Miss Amid Operational Challenges CREG Q1 2026 Earnings Loss Per Share as Stock Rises on No Estimate Surprise NEXN Q3 2025 Earnings EPS Surges Past Estimates Stock Rises 122 WhiteFiber Inc WYFI Q1 2026 Earnings EPS Misses Estimates Stock Gains 217 Despite WiderThanExpected Loss CSGP Q1 2026 Earnings EPS Surpasses Estimates by 225 but Shares Slide 42 IRON Q1 2026 Earnings Narrower Loss Beats Estimates as Disc Medicine Advances Clinical Pipeline Transdigm Group TDG Holds Near Support Resistance Tested in Recent Session CorMedix CRMD Tests Support Zone After Modest Decline CooperStandard Holdings CPS Surges Over 5 on High Volume Technicals Point to Further Upside Potential Dynamix Corporation Warrant ETHMW Holds Steady at 017 as Traders Eye Tight Range Opendoor Technologies OPEN Faces Resistance Near 476 as Stock Slips 088 Retailers Navigate KShaped Economy With Price Cuts and Premiumization Strategies EGBN Q1 2026 Earnings EPS Surges Past Estimates on Strong Margin and Lower Provisions QuidelOrtho QDEL Drops 43 as Diagnostics Sector Faces Renewed Pressure Value Line Inc Q1 2026 Earnings EPS of 069 Surprises Despite Revenue Silence CV Q1 2026 Earnings EPS Misses Estimates as Stock Declines Addentax Group Corp ATXG Q1 2025 Earnings Net Loss Reported Amid Modest Stock Gain ADT Inc Q1 2026 Earnings EPS Beat Bolsters Margins Despite Revenue Discreetness Park Hotels Resorts Q1 2026 Earnings EPS Surprises by 7696 Amid Rebounding Travel Demand PAGP Q1 2026 Earnings Strong EPS Surprise of 1197 Despite Revenue Uncertainty C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution